Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR): $16.62

0.17 (+1.03%)

POWR Rating

Component Grades

Buy & Hold

B

Peer

D

Add CNCR to Watchlist
Sign Up

Category: Health & Biotech ETFs

Category

C

Ranked

#31 of 42

in category

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $16.62 52-week high $17.96
Prev. close $16.45 52-week low $9.22
Day low $16.48 Volume 12,300
Day high $16.78 Avg. volume 34,341
50-day MA $15.75 Dividend yield N/A
200-day MA $12.85

CNCR Stock Price Chart Interactive Chart >


Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

CNCR ETF Info

Issuer Range ETFs
Expense Ratio 0.79%
Underlying Index Range Cancer Therapeutics Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 17.12M
Net Asset Value (NAV) $16.62
Options? Yes
Total Holdings N/A

CNCR Top Holdings

Symbol Company % of Total

CNCR Price Returns

1-mo -3.93%
3-mo 23.39%
6-mo 51.71%
1-year 39.43%
3-year -38.43%
5-year -14.13%
YTD 23.39%
2023 -1.89%
2022 -42.31%
2021 -19.24%
2020 36.53%
2019 24.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!